The Medspa Economy: How Beauty Became a High-Stakes Identity Game

NEW YORK, NY – September 29, 2026 — There is a quiet revolution happening in American retail real estate, and it has nothing to do with e-commerce or the death of the shopping mall. Today, there are nearly 13,000 medical spas operating across the United States. To understand the sheer scale of that footprint, consider this: it closely matches the domestic presence of McDonald's, which hovers around 13,700 locations. Beauty, health, and wellness (BHW) have transcended the realm of discretionary luxury. They have become the infrastructure of modern identity.

Yet, as the physical landscape of wellness expands, a comprehensive new report from global consulting firm AlixPartners and CEW (Cosmetic Executive Women) reveals a startling strategic misfire at the top of the industry. The executives running these multi-billion-dollar brands are fundamentally misunderstanding the modern consumer. They are directing capital toward outdated marketing channels, ignoring massive demographic shifts, and misjudging the speed at which clinical interventions are rewiring consumer expectations.

"The Extract: Beauty × Health × Wellness 2026," which surveyed 1,000 consumers and nearly 130 industry executives, exposes a profound disconnect between boardroom strategies and consumer realities. As BHW morphs into a clinical, high-stakes occupation for the American consumer, the brands that fail to adapt to this new paradigm risk leaving billions on the table.

The 'Looksmaxxing' Economy and the Male Spender

Perhaps the most glaring blind spot for legacy beauty executives is the sudden, overwhelming arrival of young men into the aesthetic market. For decades, the strategic rationale in beauty boardrooms was simple: market to women, treat men as an ancillary grooming category. That logic is now entirely obsolete.

Driven by internet subcultures and the normalization of male aesthetic enhancement—often dubbed "looksmaxxing"—Gen Z and Millennial men are not just participating in the BHW market; they are dominating its growth. In 2024 alone, 1.6 million American men underwent cosmetic procedures. Clinical data shows cheek implants among men rose by 3.6% year-over-year, neuromodulator injections by 4.3%, and skin resurfacing by 6.1%.

But the spending data reveals an even more aggressive shift. According to the AlixPartners report, Gen Z and Millennial men are 2.7 times more likely to spend over $500 monthly on BHW than the general population. Nearly half (49%) spend more than 1.5 hours daily on these routines, compared to just 28% of the broader public. Astoundingly, 60% of the "first-to-know" early-adopter consumer segment are male.

"As BHW has adapted into an all-encompassing project for the consumer, their discovery channels, their budget prioritization, and interest in emerging tools and trends have totally changed, but the average executive has yet to catch up," noted Lindy Firstenberg, Co-Leader of the Beauty × Health × Wellness Practice at AlixPartners. Men are approaching wellness with a strategic, protocol-driven mindset, heavily favoring subscriptions and clinical consistency. Brands that continue to view beauty as an exclusively female domain are effectively cutting their addressable market in half.

The Trust Deficit and the Death of the Influencer

If ignoring the male spender is a failure of demographic targeting, the industry's continued reliance on influencer marketing is a failure of capital allocation. For years, the beauty industry has treated social media influencers as the ultimate distribution channel, funneling massive portions of their marketing budgets into sponsored posts and curated aesthetics. Executives surveyed in the report consistently ranked influencers as a top discovery channel.

The consumers, however, tell a vastly different story. When asked who they actually trust, influencers ranked a dismal fifth, barely registering at 32%—essentially tied with generic online searches. Instead, consumers are seeking validation from close circles and clinical authorities. Friends and family lead at 45% (a 15-point gap from executive perception), followed closely by healthcare practitioners at 38% (a stunning 22-point gap from the 16% of executives who value this channel).

This trust deficit is being exacerbated by what industry analysts are calling the "pharmification effect." The explosive rise of GLP-1 weight-loss drugs like Ozempic has fundamentally altered the consumer psyche. Fifty-one percent of consumers report that GLP-1s have raised or reset their expectations for BHW products and treatments. They no longer have the patience for a six-week topical cream regimen when pharmaceutical interventions offer rapid, visible transformations.

Elana Drell Szyfer, President of CEW, articulated this perfectly: "There is a huge trust gap. Consumers want results faster than is sometimes possible and, at the same time, are skeptical of product claims, some going off-label or into the grey market to pursue their goals... women are telling us they want human support. They want to be known by someone who understands their skin, their age, their life stage, and they don’t trust paid actors."

The Femtech Blindspot and the Intimate Health Void

While executives are busy chasing influencers, they are actively ignoring the most pressing medical and wellness needs of their core female demographic. In recent years, venture capital has flowed into menopause care, generating celebrity-backed brands and sleek packaging. Yet, this surface-level investment masks a deeply entrenched systemic neglect of women's sexual and vaginal health.

The AlixPartners data is damning: 34% of women state that low libido and sexual health are drastically underrepresented by brand investments, and 37% say vaginal and intimate health are entirely underserved. The regulatory landscape highlights this inequity with brutal clarity. The FDA has approved 26 erectile dysfunction medications for men. For women suffering from low libido, there are exactly two.

Instead of funding rigorous clinical solutions, the BHW industry has attempted to fill this void with extra-medical shortcuts—supplements, topicals, and lifestyle branding—that fail to address the root physiological needs of women. It is a classic market failure: high demand, zero credible supply, and executives looking the other way because the subject matter doesn't fit neatly into a traditional beauty counter aesthetic.

The Medicalization of the Beauty Counter

The convergence of these trends—the male procedural boom, the demand for clinical efficacy, and the rejection of influencer aesthetics—points to a singular strategic conclusion: the traditional retail beauty model is becoming obsolete. The future of the industry lies in the "magic medspa" model, a hybrid of concierge medicine and integrated wellness.

This explains why the medspa footprint has exploded to rival fast-food chains, growing by over 150% since 2017 into a $17 billion domestic market. Consumers are voting with their wallets, and they are choosing integrated, practitioner-led spaces offering diagnostics, custom compounds, and IV drips over department store counters.

More importantly, they are prioritizing this spending above nearly everything else. Sixty-three percent of consumers now rank health and wellness as their top discretionary spending priority, beating out travel, fashion, and entertainment.

"Our study has made it abundantly clear that we're seeing a fundamental recalibration: BHW has become an identity purchase," explained Catherine Nekavand, Co-Leader of the Beauty × Health × Wellness Practice at AlixPartners. "BHW used to compete with travel, fashion, and dining for consumer dollars. Now, they're competing with the mortgage and the grocery bill. Consumers are saying: 'This is non-negotiable.'"

For the executives clinging to the old playbook of celebrity partnerships and gender-siloed marketing, the message is clear. The quiet moves defining the next decade of the global economy are not happening on social media feeds, but rather in clinical treatment rooms driven by a consumer base that is younger, increasingly male, and utterly ruthless in its demand for real, medically validated results.